The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase*

Background: Deoxyguanosine kinase (dGK) deficiency causes mtDNA depletion in quiescent cells where SAMHD1 restricts dGTP concentration. Results: siRNA silencing of SAMHD1 corrects mt dNTP imbalance boosting mtDNA content in quiescent dGK-mutated human fibroblasts. Conclusion: In noncycling cells SAMHD1 activity worsens the phenotype of dGK genetic deficiency, limiting dGTP supply. Significance: Nuclear SAMHD1 and mitochondrial dGK functionally interact in the regulation of mt dGTP for mtDNA maintenance. The dNTP triphosphohydrolase SAMHD1 is a nuclear antiviral host restriction factor limiting HIV-1 infection in macrophages and a major regulator of dNTP concentrations in human cells. In normal human fibroblasts its expression increases during quiescence, contributing to the small dNTP pool sizes of these cells. Down-regulation of SAMHD1 by siRNA expands all four dNTP pools, with dGTP undergoing the largest relative increase. The deoxyguanosine released by SAMHD1 from dGTP can be phosphorylated inside mitochondria by deoxyguanosine kinase (dGK) or degraded in the cytosol by purine nucleoside phosphorylase. Genetic mutations of dGK cause mitochondrial (mt) DNA depletion in noncycling cells and hepato-cerebral mtDNA depletion syndrome in humans. We studied if SAMHD1 and dGK interact in the regulation of the dGTP pool during quiescence employing dGK-mutated skin fibroblasts derived from three unrelated patients. In the presence of SAMHD1 quiescent mutant fibroblasts manifested mt dNTP pool imbalance and mtDNA depletion. When SAMHD1 was silenced by siRNA transfection the composition of the mt dNTP pool approached that of the controls, and mtDNA copy number increased, compensating the depletion to various degrees in the different mutant fibroblasts. Chemical inhibition of purine nucleoside phosphorylase did not improve deoxyguanosine recycling by dGK in WT cells. We conclude that the activity of SAMHD1 contributes to the pathological phenotype of dGK deficiency. Our results prove the importance of SAMHD1 in the regulation of all dNTP pools and suggest that dGK inside mitochondria has the function of recycling the deoxyguanosine derived from endogenous dGTP degraded by SAMHD1 in the nucleus.

[1]  M. Washburn,et al.  CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain* , 2015, The Journal of Biological Chemistry.

[2]  F. Lasitschka,et al.  SAMHD1's protein expression profile in humans , 2015, Journal of leukocyte biology.

[3]  G. Agrimi,et al.  The Human SLC25A33 and SLC25A36 Genes of Solute Carrier Family 25 Encode Two Mitochondrial Pyrimidine Nucleotide Transporters* , 2014, The Journal of Biological Chemistry.

[4]  A. Gronenborn,et al.  Structural Basis of Allosteric Activation of Sterile α Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates* , 2014, The Journal of Biological Chemistry.

[5]  Y. Xiong,et al.  Structural basis of cellular dNTP regulation by SAMHD1 , 2014, Proceedings of the National Academy of Sciences.

[6]  Daehyun Baek,et al.  The ribonuclease activity of SAMHD1 is required for HIV-1 restriction , 2014, Nature Medicine.

[7]  B. Clotet,et al.  Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of SAMHD1 in Myeloid and Lymphoid Cells , 2014, The Journal of Immunology.

[8]  P. Reichard,et al.  Allosteric Regulation of the Human and Mouse Deoxyribonucleotide Triphosphohydrolase Sterile α-Motif/Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) , 2014, The Journal of Biological Chemistry.

[9]  M. Hirano,et al.  Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. , 2014, Human molecular genetics.

[10]  P. Li,et al.  Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase , 2013, Nature Communications.

[11]  A. Gronenborn,et al.  Mechanism of Allosteric Activation of SAMHD1 by dGTP , 2013, Nature Structural &Molecular Biology.

[12]  J. Rehwinkel,et al.  SAMHD1-dependent retroviral control and escape in mice , 2013, Retrovirology.

[13]  Werner Müller,et al.  Mouse SAMHD1 Has Antiretroviral Activity and Suppresses a Spontaneous Cell-Intrinsic Antiviral Response , 2013, Cell reports.

[14]  P. Reichard,et al.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells , 2013, Proceedings of the National Academy of Sciences.

[15]  Ying Wu,et al.  HIV-2 and SIVmac Accessory Virulence Factor Vpx Down-regulates SAMHD1 Enzyme Catalysis Prior to Proteasome-dependent Degradation* , 2013, The Journal of Biological Chemistry.

[16]  M. Benkirane,et al.  Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.

[17]  Baek Kim,et al.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. , 2013, Cell host & microbe.

[18]  B. Nocek,et al.  Nuclease Activity of the Human SAMHD1 Protein Implicated in the Aicardi-Goutières Syndrome and HIV-1 Restriction* , 2013, The Journal of Biological Chemistry.

[19]  P. Laveder,et al.  Synthesis of Mitochondrial DNA Precursors during Myogenesis, an Analysis in Purified C2C12 Myotubes , 2013, The Journal of Biological Chemistry.

[20]  V. Bianchi,et al.  The pyrimidine nucleotide carrier PNC1 and mitochondrial trafficking of thymidine phosphates in cultured human cells. , 2012, Experimental cell research.

[21]  Baek Kim,et al.  Tight Interplay among SAMHD1 Protein Level, Cellular dNTP Levels, and HIV-1 Proviral DNA Synthesis Kinetics in Human Primary Monocyte-derived Macrophages* , 2012, The Journal of Biological Chemistry.

[22]  Baek Kim,et al.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.

[23]  Thomas Hollis,et al.  Aicardi-Goutières Syndrome Gene and HIV-1 Restriction Factor SAMHD1 Is a dGTP-regulated Deoxynucleotide Triphosphohydrolase*♦ , 2011, The Journal of Biological Chemistry.

[24]  Geoff Kelly,et al.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.

[25]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[26]  K. Sakumi,et al.  Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase. , 2010, Mutation research.

[27]  P. Reichard,et al.  Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. , 2010, Mutation research.

[28]  P. Reichard,et al.  Quantitation of cellular deoxynucleoside triphosphates , 2009, Nucleic acids research.

[29]  E. García-Arumí,et al.  Quantification of mitochondrial DNA copy number: pre-analytical factors. , 2009, Mitochondrion (Amsterdam. Print).

[30]  Jonathan C. Fuller,et al.  Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.

[31]  C. Tse,et al.  Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[32]  V. Bianchi,et al.  Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2‐mutated fibroblasts , 2009, The FEBS journal.

[33]  M. Zeviani,et al.  Clinical and molecular features of mitochondrial DNA depletion syndromes , 2009, Journal of Inherited Metabolic Disease.

[34]  Ann Saada Mitochondrial deoxyribonucleotide pools in deoxyguanosine kinase deficiency. , 2008, Molecular genetics and metabolism.

[35]  L. Leanza,et al.  Metabolic Interrelations within Guanine Deoxynucleotide Pools for Mitochondrial and Nuclear DNA Maintenance* , 2008, Journal of Biological Chemistry.

[36]  J. Tyson McDonald,et al.  Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase γ replication fidelity , 2008, Nucleic acids research.

[37]  P. Reichard,et al.  p53R2-dependent Ribonucleotide Reduction Provides Deoxyribonucleotides in Quiescent Human Fibroblasts in the Absence of Induced DNA Damage* , 2007, Journal of Biological Chemistry.

[38]  J. Balzarini,et al.  Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts. , 2006, Biochemical and biophysical research communications.

[39]  Laura Crocco,et al.  Mitochondrial Deoxynucleotide Pools in Quiescent Fibroblasts , 2005, Journal of Biological Chemistry.

[40]  T. Kunkel,et al.  DNA precursor asymmetries in mammalian tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Zeviani,et al.  Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. , 2005, Molecular genetics and metabolism.

[42]  P. Reichard,et al.  Mitochondrial Deoxyribonucleotides, Pool Sizes, Synthesis, and Regulation* , 2004, Journal of Biological Chemistry.

[43]  Yurong Lai,et al.  Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.

[44]  V. Bianchi,et al.  Mammalian 5′-Nucleotidases* , 2003, Journal of Biological Chemistry.

[45]  H. Mandel,et al.  Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency. , 2003, Biochemical and biophysical research communications.

[46]  P. Reichard,et al.  Origins of mitochondrial thymidine triphosphate: Dynamic relations to cytosolic pools , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Muddle,et al.  Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. , 2003, Human molecular genetics.

[48]  Ann Saada,et al.  mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. , 2003, Molecular genetics and metabolism.

[49]  K. Johansson,et al.  Structure and function of cellular deoxyribonucleoside kinases , 2002, Cellular and Molecular Life Sciences CMLS.

[50]  H. Mandel,et al.  The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA , 2001, Nature Genetics.

[51]  R. Furneaux,et al.  Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Reichard,et al.  Cytosolic High K m 5′-Nucleotidase and 5′(3′)-Deoxyribonucleotidase in Substrate Cycles Involved in Nucleotide Metabolism* , 2001, The Journal of Biological Chemistry.

[53]  Nan Li,et al.  Identification of human homologue of mouse IFN-γ induced protein from human dendritic cells , 2000 .

[54]  L. Thompson,et al.  SCID: the role of adenosine deaminase deficiency. , 1997, Immunology today.

[55]  D. Jenssen,et al.  Molecular analysis of mutations in the hprt gene of V79 hamster fibroblasts: effects of imbalances in the dCTP, dGTP and dTTP pools. , 1995, Journal of molecular biology.

[56]  G. Juliusson,et al.  Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues. , 1995, European journal of cancer.

[57]  Elias S. J. Arnér,et al.  Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. , 1992, Biochemical and biophysical research communications.

[58]  M. Markert,et al.  Purine nucleoside phosphorylase deficiency , 2020, Atlas of Inherited Metabolic Diseases.

[59]  J. A. Fyfe,et al.  Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. , 1989, Analytical biochemistry.

[60]  P. Reichard,et al.  Interactions between deoxyribonucleotide and DNA synthesis. , 1988, Annual review of biochemistry.

[61]  P. Garland,et al.  [2] Citrate synthase from rat liver: [EC 4.1.3.7 Citrate oxaloacetage-lyase (CoA-acetylating)] , 1969 .